首页> 美国卫生研究院文献>Oncotarget >SSCMDA: spy and super cluster strategy for MiRNA-disease association prediction
【2h】

SSCMDA: spy and super cluster strategy for MiRNA-disease association prediction

机译:SSCMDA:MiRNA-疾病关联预测的间谍和超级聚类策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the biological field, the identification of the associations between microRNAs (miRNAs) and diseases has been paid increasing attention as an extremely meaningful study for the clinical medicine. However, it is expensive and time-consuming to confirm miRNA-disease associations by experimental methods. Therefore, in recent years, several effective computational models for predicting the potential miRNA-disease associations have been developed. In this paper, we proposed the Spy and Super Cluster strategy for MiRNA-Disease Association prediction (SSCMDA) based on known miRNA-disease associations, integrated disease similarity and integrated miRNA similarity. For problems of mixed unknown miRNA-disease pairs containing both potential associations and real negative associations, which will lead to inaccurate prediction, spy strategy is adopted by SSCMDA to identify reliable negative samples from the unknown miRNA-disease pairs. Moreover, the super-cluster strategy could gather as many positive samples as possible to improve the accuracy of the prediction by overcoming the shortage of lacking sufficient positive training samples. As a result, the AUCs of global leave-one-out cross validation (LOOCV), local LOOCV and 5-fold cross validation were 0.9007, 0.8747 and 0.8806+/-0.0025, respectively. According to the AUC results, SSCMDA has shown a significant improvement compared with some previous models. We further carried out case studies based on various version of HMDD database to test the prediction performance robustness of SSCMDA. We also implemented case study to examine whether SSCMDA was effective for new diseases without any known associated miRNAs. As a result, a large proportion of the predicted miRNAs have been verified by experimental reports.
机译:在生物学领域中,作为临床医学的极其有意义的研究,对微小RNA(miRNA)与疾病之间的关联的鉴定日益受到关注。然而,通过实验方法确认miRNA-疾病关联是昂贵且费时的。因此,近年来,已经开发了几种用于预测潜在的miRNA-疾病关联的有效计算模型。在本文中,我们基于已知的miRNA-疾病关联,整合的疾病相似性和集成的miRNA相似性,提出了针对MiRNA-疾病关联预测(SSCMDA)的间谍和超级聚类策略。对于既包含潜在关联又包含真实负关联的未知miRNA疾病混合对的问题,这将导致预测不准确,SSCMDA采用间谍策略从未知miRNA疾病对中识别可靠的阴性样品。此外,超级聚类策略可以通过克服缺乏足够的正训练样本的不足来收集尽可能多的正样本,以提高预测的准确性。结果,全局留一法交叉验证(LOOCV),局部LOOCV和5倍交叉验证的AUC分别为0.9007、0.8747和0.8806 +/- 0.0025。根据AUC结果,与以前的某些模型相比,SSCMDA已显示出明显的改进。我们还基于各种版本的HMDD数据库进行了案例研究,以测试SSCMDA的预测性能鲁棒性。我们还进行了案例研究,以检查SSCMDA是否对没有任何已知相关miRNA的新疾病有效。结果,实验报告证实了大部分预测的miRNA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号